Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat

Purpose The prognosis of patients ≥ 75 years suffering from glioblastoma is poor. Novel therapies are usually reserved for patients ≤ 70 years. In an aging population, treatment of very elderly patients remains a challenge. Methods Between 2010 and 2018, a total of 977 glioblastoma patients were tre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neuro-oncology 2023-12, Vol.165 (3), p.509-515
Hauptverfasser:	Baumgarten, Peter, Prange, Georg, Kamp, Marcel A., Monden, Daniel, Neef, Vanessa, Schwarzer, Franziska, Dubinski, Daniel, Dinc, Nazife, Weber, Katharina J., Czabanka, Markus, Hattingen, Elke, Ronellenfitsch, Michael W., Steinbach, Joachim P., Senft, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant therapy Aged Aging Antineoplastic Agents, Alkylating - therapeutic use Biopsy Brain cancer Brain Neoplasms - drug therapy Chemotherapy Combined Modality Therapy Geriatrics Glioblastoma Glioblastoma - drug therapy Humans Medical prognosis Medicine Medicine & Public Health Multivariate analysis Neurology Oncology Patients Prognosis Radiation therapy Retrospective Studies Survival Temozolomide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!